How does ED prevalence vary among cancer survivors, with prostate cancer survivors showing the highest rates, and how do different cancer treatments compare in their impact on sexual health?

September 25, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic Fatty Liver Strategy, has been designed to improve the health of your liver just by eliminating the factors and reversing the effects caused by your fatty liver. It has been made an easy-to-follow program by breaking it up into lists of recipes and stepwise instructions. Everyone can use this clinically proven program without any risk. You can claim your money back within 60 days if its results are not appealing to you.


How does ED prevalence vary among cancer survivors, with prostate cancer survivors showing the highest rates, and how do different cancer treatments compare in their impact on sexual health?

Erectile dysfunction (ED) is highly prevalent among cancer survivors, with rates varying significantly depending on the type of cancer and its treatment, but prostate cancer survivors consistently report the highest rates, often exceeding 80%. This is because treatments for pelvic cancers, particularly prostate cancer, such as radical surgery and radiation therapy, directly damage the delicate nerves and blood vessels essential for erectile function. In comparison, treatments like chemotherapy and hormone therapy can also cause ED, but often through systemic effects like hormonal imbalances and fatigue, resulting in different and sometimes less severe impacts on sexual health.

🎗️ The Widespread Impact of Cancer on Male Sexual Health

Erectile dysfunction is a common and distressing consequence for many male cancer survivors, yet its prevalence and severity differ dramatically across various cancer diagnoses. While any major illness can impact sexual health, cancers located within the pelvic region and those requiring treatments that affect hormonal or neurological systems pose the greatest risk. Survivors of colorectal, bladder, and testicular cancer frequently experience high rates of ED, often ranging from 30% to 60%. These cancers are anatomically close to the crucial neurovascular structures that control erections, and treatments can easily cause collateral damage. However, even survivors of cancers outside the pelvis, such as hematological (blood) cancers or head and neck cancers, can experience ED due to the systemic effects of treatment, including fatigue, psychological distress, and changes in body image. The experience of a cancer diagnosis itself is a significant psychological stressor that can contribute to sexual dysfunction, creating a complex interplay of physical and emotional factors that must be addressed.

prostate 👑 Prostate Cancer Survivors: The Highest Rate of Erectile Dysfunction

Among all cancer survivor populations, men who have been treated for prostate cancer experience the highest and most widely documented rates of erectile dysfunction. The prevalence is staggering, with most studies reporting that between 60% and 90% of survivors will experience some degree of long-term ED. The reason for this exceptionally high rate is purely anatomical. The prostate gland is intimately wrapped around the urethra and is surrounded by a delicate web of nerves and blood vessels known as the cavernous nerves. These nerves are the primary messengers that trigger the increase in blood flow required to achieve an erection. Any treatment aimed at eradicating cancer within the prostate gland carries an extremely high risk of damaging these fragile structures, either by direct surgical removal, radiation-induced scarring, or other therapeutic insults. Because the prostate is central to both urinary and sexual function, treatments designed to save a man’s life often come at a very high cost to his sexual function.

💥 A Comparison of Cancer Treatment Impacts on Sexual Health 🔪

The type of cancer treatment a man receives is the single most important predictor of his future sexual function. The impact of each modality varies significantly based on its mechanism of action and the area of the body being treated.

Surgery: Radical prostatectomy, the surgical removal of the prostate gland, is the treatment most associated with severe ED. Even with modern “nerve-sparing” techniques, where surgeons meticulously try to dissect the cavernous nerves away from the prostate before its removal, some degree of nerve damage is almost inevitable. The stretching, pulling, and thermal energy used during surgery can bruise or permanently injure the nerves, disrupting their ability to send erection-triggering signals. For other pelvic surgeries, like radical cystectomy (bladder removal) or abdominoperineal resection (for rectal cancer), the risk is also very high due to the extensive dissection required in the same neurovascular territory.

Radiation Therapy: Both external beam radiation therapy (EBRT) and brachytherapy (internal radiation seeds) can cause a more gradual but progressive decline in erectile function. Radiation damages the DNA of cells, and while it targets cancer, it also affects healthy tissue. Over time, radiation causes fibrosis (scarring) and damage to the small blood vessels and nerves that supply the penis. This leads to a slow hardening and narrowing of the arteries, a condition known as radiation-induced vasculopathy, which steadily diminishes blood flow. Unlike the often-immediate effects of surgery, radiation-induced ED can develop over months or even years following treatment.

Hormone Therapy: Also known as androgen deprivation therapy (ADT), hormone therapy is a common treatment for advanced prostate cancer. It works by drastically reducing the body’s level of testosterone. While effective at slowing cancer growth, it has a devastating impact on sexual function. Testosterone is the primary driver of libido (sexual desire), and its absence almost universally extinguishes it. Without libido, erections are difficult to achieve even with physical stimulation. ADT effectively causes a medical castration, and ED is an expected and near-certain side effect for the duration of the therapy.

Chemotherapy: The impact of chemotherapy on ED is more variable and less direct. As a systemic treatment, chemotherapy can cause widespread side effects, including profound fatigue, nausea, and psychological distress, all of which can suppress sexual desire and function. In some cases, certain chemotherapy agents can cause nerve damage (neuropathy) or affect testosterone production, but its primary impact is often through its toll on a patient’s overall health and well-being rather than direct damage to the erectile mechanism itself. For many men, erectile function returns after chemotherapy is completed and their strength recovers.


The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic Fatty Liver Strategy, has been designed to improve the health of your liver just by eliminating the factors and reversing the effects caused by your fatty liver. It has been made an easy-to-follow program by breaking it up into lists of recipes and stepwise instructions. Everyone can use this clinically proven program without any risk. You can claim your money back within 60 days if its results are not appealing to you

Mr.Hotsia

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more